Metabolic Endocrinology Diabetic Neuropathy

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Diabetic Neuropathy Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Diabetic Neuropathy Projects
--Astellas Pharma Inc
--Alinea Pharmaceuticals, Inc.
--DAIICHI SANKYO COMPANY, LIMITED
--Creative Peptides Sweden AB
--Depomed Inc
--Dainippon Sumitomo Pharma Co., Ltd.
--Eisai Co Ltd
--Dov Pharmaceutical Inc
--Kyorin Co., Ltd.
--GW Pharmaceuticals PLC
--Sangamo BioSciences Inc
--Mitsubishi Tanabe Pharma Corporation
--Sanwa Kagaku Kenkyusho Co., Ltd.
--Sanofi-Aventis
--Sigma-Tau S.p.A.
--Schwarz Pharma Ag
--The Quigley Corporation
--Takeda Pharmaceutical Company Limited
--UCB S.A.
--Trophos SA

--Top Companies in early stage Diabetic Neuropathy Projects
--Milkhaus Laboratory, Inc.
--t2cure GmbH
--Warren Pharmaceuticals, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View